Newell Eric R
Newell Eric R's purchase track record
How the stock did after each of Newell Eric R's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/14/2025 | EGBN | $50K | +57.7% | +47.0% | +10.0% |
| 3/7/2025 | EGBN | $25K | -19.1% | -6.5% | +12.3% |
| 6/11/2024 | EGBN | $16K | +28.9% | +80.1% | +12.3% |
| 5/29/2024 | EGBN | $17K | +29.8% | +76.9% | +13.9% |
| 4/29/2024 | EGBN | $29K | +15.4% | +44.2% | +13.8% |
| 3/10/2023 | EQBK | $82K | -11.8% | -11.9% | +15.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
EQBK Q3 Earnings Beat Estimates Despite Revenue Miss. Equity Bancshares reported Q3 results that exceeded earnings estimates but missed on revenue, causing the stock to fall over 5%. The mixed performance keeps attention on the company's margin and the pending Lincoln deal. The stock is currently trading near its 52-week low, reflecting investor caution despite the earnings beat.
Transaction History
| EGBN | ▲ Buy | Grant | 4,086 | $0 | 3/16/2026 | View on chart |
| EGBN | ▲ Buy | Grant | 5,248 | $0 | 2/19/2026 | View on chart |
| EGBN | ▲ Buy | Open Market | 3,050 | $50K | 11/14/2025 | View on chart |
| EGBN | ▲ Buy | Open Market | 1,170 | $25K | 3/7/2025 | View on chart |
| EGBN | ▲ Buy | Grant | 6,576 | $0 | 2/26/2025 | View on chart |
| EGBN | ▲ Buy | Open Market | 987 | $16K | 6/11/2024 | View on chart |
| EGBN | ▲ Buy | Open Market | 1,000 | $17K | 5/29/2024 | View on chart |
| EGBN | ▲ Buy | Open Market | 1,000 | $19K | 4/30/2024 | View on chart |
| EGBN | ▲ Buy | Open Market | 572 | $11K | 4/29/2024 | View on chart |
| EGBN | ▲ Buy | Grant | 3,297 | $0 | 2/12/2024 | View on chart |
| EGBN | ▲ Buy | Grant | 13,818 | $0 | 9/25/2023 | View on chart |
| EQBK | ▲ Buy | Open Market | 1,000 | $27K | 3/14/2023 | View on chart |
| EQBK | ▲ Buy | Open Market | 2,000 | $55K | 3/10/2023 | View on chart |
| EQBK | ▲ Buy | Grant | 3,820 | $0 | 1/30/2023 | View on chart |
| EQBK | ▲ Buy | Grant | 3,820 | $0 | 1/30/2023 | View on chart |
| EQBK | ▲ Buy | Grant | 6,188 | $0 | 1/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
EGBN among regional banks set for higher short‑term rates
EGBN was named in a Yahoo piece as one of three regional banks positioned to benefit from higher short‑term rates. Rising rates can widen net interest margins for banks that lend at longer terms, which may support earnings growth. The stock sits near a key support level of $27.71 and trades with a 60.3 RSI, while its 7.59% dividend yield remains attractive to income‑focused investors.
EGBN among regional banks set for higher short‑term rates. EGBN was named in a Yahoo piece as one of three regional banks positioned to benefit from higher short‑term rates. Rising rates can widen net interest margins for banks that lend at longer terms, which may support earnings growth. The stock sits near a key support level of $27.71 and trades with a 60.3 RSI, while its 7.59% dividend yield remains attractive to income‑focused investors.